Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Amplia Therapeutics (ATX)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
EBR Systems (EBR)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Patrys (PAB)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
July 10th, 2025
Strong Profit Upgrade from Cogstate
Read More
January 28th, 2025
Wheels in Motion for Cogstate
Read More
October 29th, 2024
Cogstate Positioned for Top and Bottom Line Growth in FY2025
Read More
July 10th, 2024
Donanemab Approved for Alzheimer's Disease; Positive News for Cogstate
Read More
October 10th, 2023
Acquisition Targets for Australian Biotech Sector (Cogstate)
Read More
September 4th, 2023
Disappointing Half Year Sales for Cogstate; Pipeline for New Contracts at All-time High Levels
Read More
May 19th, 2023
Cogstate - Eli Lilly's Donanemab Confirms Benefit of Beta Amyloid Drugs for Alzheimer's
Read More
February 24th, 2023
Cogstate Acquisition Discussions Halted
Read More
December 19th, 2022
Lecanemab Data Presented; Positive News for Cogstate
Read More
November 4th, 2022
Cogstate Signs US$17.9 Million of Contracts in September Quarter
Read More
October 5th, 2022
Eisai Delivers Positive Phase III Alzheimer's Data
Read More
September 19th, 2022
Cogstate - Investors Await Lecanemab Phase III Data
Read More
August 5th, 2022
Cogstate Annual Sales up 74% to US$82.5 Million
Read More
May 25th, 2022
Bioshares Biotech Summit Conference Coverage - Cogstate
Read More
May 3rd, 2022
Cogstate Reports Record - Sales Up 105%
Read More
February 28th, 2022
Cogstate Half-Year Results
Read More
January 28th, 2022
Cogstate - US$13.7 Million of Sales Contracts Signed
Read More
Pages
1
